These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22753648)

  • 41. Computed tomography guided intra-articular injection of etanercept in the sacroiliac joint is an effective mode of treatment of ankylosing spondylitis.
    Cui Y; Xiao Z; Shuxia W; Zhenjun Z; Hengguo Z; Liangyi F; Weicheng G; Li L; Guangfeng Z; Yunzhen S; Guangfu D
    Scand J Rheumatol; 2010 May; 39(3):229-32. PubMed ID: 20109079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI.
    Althoff CE; Sieper J; Song IH; Haibel H; Weiß A; Diekhoff T; Rudwaleit M; Freundlich B; Hamm B; Hermann KG
    Ann Rheum Dis; 2013 Jun; 72(6):967-73. PubMed ID: 22736088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic resonance imaging assessment of spinal inflammation in patients treated for ankylosing spondylitis.
    Treitl M; Korner M; Becker-Gaab C; Tryzna M; Rieger J; Pfeifer KJ; Reiser MF; Wirth S
    J Rheumatol; 2008 Jan; 35(1):126-36. PubMed ID: 18061979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.
    Maksymowych WP; Baraliakos X; Lambert RG; Landewé R; Sandoval D; Carlier H; Lisse J; Li X; Hojnik M; Østergaard M
    Lancet Rheumatol; 2022 Sep; 4(9):e626-e634. PubMed ID: 38288892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Marked reduction of sacroiliac joint inflammation on magnetic resonance imaging in a patient with ankylosing spondylitis after rituximab treatment.
    Huang Y; Cheng F; Zhang X; Tang J
    J Rheumatol; 2011 Sep; 38(9):2083-4. PubMed ID: 21885528
    [No Abstract]   [Full Text] [Related]  

  • 46. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
    Hermann KG; Landewé RB; Braun J; van der Heijde DM
    J Rheumatol; 2005 Oct; 32(10):2056-60. PubMed ID: 16206370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.
    Sieper J; van der Heijde D; Dougados M; Maksymowych WP; Scott BB; Boice JA; Berd Y; Bergman G; Curtis S; Tzontcheva A; Huyck S; Weng HH
    Arthritis Rheumatol; 2015 Oct; 67(10):2702-12. PubMed ID: 26139307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of low-dose infliximab on spinal inflammation on magnetic resonance imaging in ankylosing spondylitis.
    Rudwaleit M
    J Rheumatol; 2010 Aug; 37(8):1553-5. PubMed ID: 20675850
    [No Abstract]   [Full Text] [Related]  

  • 49. Magnetic Resonance Imaging of Lesions in the Sacroiliac Joints for Differentiation of Patients With Axial Spondyloarthritis From Control Subjects With or Without Pelvic or Buttock Pain: A Prospective, Cross-Sectional Study of 204 Participants.
    Seven S; Østergaard M; Morsel-Carlsen L; Sørensen IJ; Bonde B; Thamsborg G; Lykkegaard JJ; Hendricks O; Jørgensen NR; Pedersen SJ
    Arthritis Rheumatol; 2019 Dec; 71(12):2034-2046. PubMed ID: 31309740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab.
    Sieper J; Baraliakos X; Listing J; Brandt J; Haibel H; Rudwaleit M; Braun J
    Rheumatology (Oxford); 2005 Dec; 44(12):1525-30. PubMed ID: 16091396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis.
    Bredella MA; Steinbach LS; Morgan S; Ward M; Davis JC
    AJR Am J Roentgenol; 2006 Dec; 187(6):1420-6. PubMed ID: 17114530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of tumor necrosis factor α inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis.
    Huang Y; Chen Y; Liu T; Lin S; Yin G; Xie Q
    PLoS One; 2020; 15(12):e0244788. PubMed ID: 33382842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort.
    Chung HY; Machado P; van der Heijde D; D'Agostino MA; Dougados M
    Ann Rheum Dis; 2012 Jun; 71(6):809-16. PubMed ID: 21989541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trial.
    Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Freundlich B; Lange E; Rudwaleit M; Sieper J
    Semin Arthritis Rheum; 2016 Feb; 45(4):404-10. PubMed ID: 26519007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysis.
    Khoury G; Combe B; Morel J; Lukas C
    Clin Exp Rheumatol; 2021; 39(2):242-252. PubMed ID: 33506749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Magnetic resonance imaging -- guided corticosteroid-infiltration of the sacroiliac joints: pain therapy of sacroiliitis in patients with ankylosing spondylitis].
    Fritz J; König CW; Günaydin I; Clasen S; Kastler B; Kötter I; Claussen CD; Pereira PL
    Rofo; 2005 Apr; 177(4):555-63. PubMed ID: 15838762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trial.
    Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Lange E; Freundlich B; Rudwaleit M; Sieper J
    Rheumatology (Oxford); 2015 Feb; 54(2):257-61. PubMed ID: 25140041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
    Baraliakos X; Davis J; Tsuji W; Braun J
    Arthritis Rheum; 2005 Apr; 52(4):1216-23. PubMed ID: 15818694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of a magnetic resonance imaging reference criterion for defining a positive sacroiliac joint magnetic resonance imaging finding in spondyloarthritis.
    Weber U; Zubler V; Pedersen SJ; Rufibach K; Lambert RG; Chan SM; Østergaard M; Maksymowych WP
    Arthritis Care Res (Hoboken); 2013 Jun; 65(6):977-85. PubMed ID: 23203670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification.
    Maksymowych WP; Morency N; Conner-Spady B; Lambert RG
    Ann Rheum Dis; 2013 Jan; 72(1):23-8. PubMed ID: 22562977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.